FEATURED/ARCHIVES (05/05/24)

×

Aripiprazole for Borderline Personality Disorder: A Review of the Clinical Effectiveness · February 2017

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Oral Naltrexone (Incorporating Alcohol Pharmacotherapies Into Medical Practice-Treatment Improvement Protocol) · January 2009

Publications (Chapters)

NCBI>Substance Abuse and Mental Health Services Administration

×

Drug Class Review: Second-Generation Antidepressant · March 2011

Publications (Books-Reports)

NCBI>Oregon Health and Science University

×

Quetiapine for Major Depressive Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Buprenorphine Subdermal Implant (Clinical Review Report) · March 2019

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Vortioxetine for Treating Major Depressive Episodes · November 2015

Publications (Guidelines)

National Institute for Health and Care Excellence

×

Lurasidone-Clinical Report (Drug Review) · May 2013

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update · March 2016

Publications (Books-Reports)

Substance Abuse and Mental Health Services Administration

×

Amisulpride for Adults with Refractory Schizophrenia: A Review of the Clinical Effectiveness and Safety · June 2011

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

ARCHIVES UPDATED APR2023 - TOP OF THE PAGE - SEARCH MORE RESOURCES